Clinical trial · Interventional
AI-Personalized Discharge Education for Patients After Lung Cancer Surgery
Effect of AI-Personalized Discharge Education on the Quality of Discharge Teaching and Recovery Outcomes in Patients After Lung Cancer Surgery: A Randomized Controlled Trial
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 19, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260919-000001
Summary
Brief summary (as posted)
This randomized controlled trial evaluates the effect of artificial intelligence (AI)-personalized discharge education on discharge teaching quality and recovery outcomes in patients after lung cancer surgery. Eligible participants will be randomly assigned in a 1:1 ratio to either an intervention group or a control group. The control group will receive routine discharge education, including verbal instructions and a standardized printed discharge booklet. The intervention group will receive the same routine education plus an AI-generated personalized discharge guidance plan based on individual clinical and care-related information. All AI-generated content will be reviewed by a responsible nurse before being provided to participants. The primary outcome is the quality of discharge teaching measured on the day of discharge. Secondary outcomes include self-efficacy for postoperative rehabilitation management and quality of life assessed one month after discharge.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer (Diagnosis) | Malignant Lung Neoplasm | CURATED_EXACT | 0.85 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| AI-Personalized Discharge Education | Behavioral | — | UNRESOLVED |
| Routine Discharge Education | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- AI-Personalized Discharge Education
- description
- Participants receive routine discharge education plus AI-personalized discharge guidance. The personalized guidance is generated based on individual clinical and care-related information and is reviewed by a responsible nurse before being provided to the participant or caregiver.
- interventionNames
- Behavioral: AI-Personalized Discharge Education
- Behavioral: Routine Discharge Education
- type
- ACTIVE_COMPARATOR
- label
- Routine Discharge Education
- description
- Participants receive routine discharge education, including verbal instructions from nursing staff and a standardized printed discharge education booklet covering medication use, wound care, respiratory exercises, physical activity, diet, follow-up, and related postoperative care.
- interventionNames
- Behavioral: Routine Discharge Education
Primary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: 1. Pathologically confirmed primary lung cancer and underwent radical lung cancer surgery by thoracoscopic or open approach, including lobectomy, pneumonectomy, or wedge resection. 2. Age 18 to 80 years. 3. Clinical stage I to III. 4. No distant organ metastasis. 5. Clinically stable after surgery, conscious, and able to perform basic listening, speaking, and reading activities, with planned discharge to home for recovery. 6. The participant or primary caregiver is able to use a smartphone and WeChat. 7. Able and willing to provide informed consent and voluntarily participate in the study. Exclusion Criteria: 1. Recurrent lung cancer or previous treatment with targeted therapy, chemotherapy, or radiotherapy. 2. Severe aphasia, cognitive impairment (MMSE \<24), or psychiatric disorders that prevent independent completion of study questionnaires. 3. Severe cardiac, hepatic, or renal dysfunction, or another malignant tumor. 4. Severe postoperative complications requiring prolonged hospitalization, such as bronchopleural fistula or major bleeding. 5. Participation in another interventional clinical study. 6. Unable to complete the 1-month follow-up because of travel or residence outside the study area after discharge.
References
Publications (0)
Data not yet available